Amsterdam Neuroscience
-
Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis
van Lierop, Z. Y. G., Wieske, L., Koel-Simmelink, M. J. A., Chatterjee, M., Dekker, I., Leurs, C. E., Willemse, E. A. J., Moraal, B., Barkhof, F., Eftimov, F., Uitdehaag, B. M. J., Killestein, J. & Teunissen, C. E., Jan 2022, In: Multiple sclerosis (Houndmills, Basingstoke, England). 28, 1, p. 102-110 9 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Reliability, construct and concurrent validity of a smartphone-based cognition test in multiple sclerosis
Lam, K. H., van Oirschot, P., den Teuling, B., Hulst, H. E., de Jong, B. A., Uitdehaag, B. M. J., de Groot, V. & Killestein, J., 2021, (E-pub ahead of print) In: Multiple sclerosis (Houndmills, Basingstoke, England).Research output: Contribution to journal › Article* › Academic › peer-review
-
Abnormalities and erythroblasts in peripheral blood of multiple sclerosis patients treated with natalizumab
van Rossum, J. A., van Kempen, Z. L. E., Schilder, L., Lissenberg-Witte, B. I., Uitdehaag, B. & Killestein, J., 2019, In: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 36, 101382.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications